- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, October 14, 2022
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
A piece by CBS News cited an article published on AJMC.com, the website of The American Journal of Managed Care® (AJMC®). The article indicated that Teva, the largest US supplier of amphetamine/dextroamphetamine (Adderall), expects shortages of the drug to persist for the next 2 to 3 months.
Becker’s Hospital Review featured an article discussing the findings of a study published in the September 2022 issue of AJMC®. The study, “Physician Response to COVID-19–Driven Telehealth Flexibility for Opioid Use Disorder,” found that most physicians want to continue using telehealth to treat opioid use disorder after the pandemic ends. The results were also highlighted by the Yale School of Medicine.
News24 cited a video interview published on AJMC.com. The video interview with Rona Z. Silkiss, MD, FACS, an oculoplastic surgeon and owner of Silkiss Eye Surgery, reviewed the use of biologics to treat thyroid eye disease.
Report Reveals Mounting Burdens of Drug Shortages on US Health System
June 27th 2025Vizient's 2024 survey reveals a sharp rise in drug shortages across US health care, with pediatric care hit especially hard and labor costs soaring—but the true impact may go far beyond limited medication access, threatening to disrupt the very foundations of how health systems operate.
Read More
Stuck in Prior Auth Purgatory: The Hidden Costs of Health Care Delays
June 19th 2025Delays, denials, and endless paperwork—prior authorization isn’t just a headache for providers; it’s a barrier for patients who need timely care, explains Colin Banas, MD, MHA, chief medical officer with DrFirst.
Listen
